NO20004528L - Cytostatiske midler - Google Patents

Cytostatiske midler

Info

Publication number
NO20004528L
NO20004528L NO20004528A NO20004528A NO20004528L NO 20004528 L NO20004528 L NO 20004528L NO 20004528 A NO20004528 A NO 20004528A NO 20004528 A NO20004528 A NO 20004528A NO 20004528 L NO20004528 L NO 20004528L
Authority
NO
Norway
Prior art keywords
enoylamino
ester
hydroxycarbamoyl
hex
ethanoic acid
Prior art date
Application number
NO20004528A
Other languages
English (en)
Other versions
NO20004528D0 (no
Inventor
Lindsey Ann Pearson
Andrew Paul Ayscough
Philip Huxley
Alan Hastings Drummond
Original Assignee
British Biotech Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharm filed Critical British Biotech Pharm
Publication of NO20004528D0 publication Critical patent/NO20004528D0/no
Publication of NO20004528L publication Critical patent/NO20004528L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

2(R eller S)-[2R-(S-hydroksy-hydroksy- karbamoylmetyl)-4-merylpentanoylamin]-2-fenyl- etansyresykJopentylester; 2(R eller S)-(3S-hydroksy- karbamoyl-2R-isobutyl-heks-5-enoylamino)-2-fenyl- etansyreisopropylester; 2(R eller S)-[2R-(S-hydroksy- karbamoylmetoksvmetyl)-4-metylpentanoylamino]-3- fenyletansyresyklopentylester; 2(R eller S)-(3S- hydroksykarbarnoyl-2R-isobutyl-heks-5-enoylamino)- 2-(4-metoksyfenyl)etansyresyklopenrylester; 2(R eller S)-(3S-hydroksykarbamoyl-2R-isoburyl-heks-5-enoyl- amino)-2-(tien-2-yl)etansyresyklopentylester; og 2(R eller S)-(3S-hydroksykarbamoyl-2R-isobutyl- heks-5-enoylamino)-2-(tien-3-yl)etansyresyklo- pentylester er cytostatiske midler.
NO20004528A 1998-03-12 2000-09-11 Cytostatiske midler NO20004528L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/GB1998/000754 WO1999046241A1 (en) 1998-03-12 1998-03-12 Cytostatic agents

Publications (2)

Publication Number Publication Date
NO20004528D0 NO20004528D0 (no) 2000-09-11
NO20004528L true NO20004528L (no) 2000-09-11

Family

ID=10825272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004528A NO20004528L (no) 1998-03-12 2000-09-11 Cytostatiske midler

Country Status (17)

Country Link
EP (1) EP1062202B1 (no)
JP (1) JP4324324B2 (no)
KR (1) KR20010041661A (no)
CN (1) CN1141292C (no)
AT (1) ATE231122T1 (no)
AU (1) AU747977B2 (no)
BR (1) BR9815717A (no)
CA (1) CA2323414C (no)
CZ (1) CZ299610B6 (no)
DE (1) DE69810817T2 (no)
GB (1) GB2349149A (no)
HU (1) HUP0100999A2 (no)
IL (2) IL137774A0 (no)
NO (1) NO20004528L (no)
NZ (1) NZ506293A (no)
PL (1) PL190637B1 (no)
WO (1) WO1999046241A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9901863D0 (en) * 1999-01-29 1999-03-17 British Biotech Pharm Antibacterial agents
WO2019039937A1 (en) 2017-08-21 2019-02-28 Stichting Vumc POLYTHERAPY FOR THE TREATMENT OF CANCER
US10925851B2 (en) 2018-03-15 2021-02-23 Regents Of The University Of Minnesota Use of Tosedostat and related compounds as analgesics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993021942A2 (en) * 1992-05-01 1993-11-11 British Biotech Pharmaceuticals Limited Use of mmp inhibitors
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
US5691381A (en) * 1995-04-18 1997-11-25 The Dupont Merck Pharmaceutical Company Hydroxamic and carbocyclic acids as metalloprotease inhibitors
EP0925278B1 (en) * 1996-09-10 2002-07-17 British Biotech Pharmaceuticals Limited Cytostatic hydroxamic acid derivatives

Also Published As

Publication number Publication date
NO20004528D0 (no) 2000-09-11
ATE231122T1 (de) 2003-02-15
GB0019414D0 (en) 2000-09-27
CA2323414C (en) 2008-05-13
PL342811A1 (en) 2001-07-02
IL137774A0 (en) 2001-10-31
CZ20003317A3 (cs) 2001-03-14
GB2349149A (en) 2000-10-25
AU6410698A (en) 1999-09-27
JP4324324B2 (ja) 2009-09-02
EP1062202B1 (en) 2003-01-15
EP1062202A1 (en) 2000-12-27
AU747977B2 (en) 2002-05-30
CA2323414A1 (en) 1999-09-16
NZ506293A (en) 2003-05-30
CN1141292C (zh) 2004-03-10
WO1999046241A1 (en) 1999-09-16
CZ299610B6 (cs) 2008-09-17
CN1286681A (zh) 2001-03-07
JP2002506057A (ja) 2002-02-26
PL190637B1 (pl) 2005-12-30
KR20010041661A (ko) 2001-05-25
BR9815717A (pt) 2000-11-07
DE69810817D1 (de) 2003-02-20
DE69810817T2 (de) 2003-11-20
IL137774A (en) 2006-07-05
HUP0100999A2 (hu) 2001-08-28

Similar Documents

Publication Publication Date Title
ATE254133T1 (de) Teilweise oder vollständige a1 agonisten - n6- heterocyclische 5'-thio sustituierte adenosinderivate
DE69918569D1 (de) Chirurgischer manipulator
DZ2744A1 (fr) Distribution d'un agent actif aérosolé.
DE69422494T2 (de) Fettarme aufstrichzusammensetzung
IT1312122B1 (it) Frigorifero con percorso di circolazione dell'aria ottimizzato.
PT1274407E (pt) Utilizacao de agonistas de ppar-gama em doencas induzidas por netrofilos
RS50071B (sr) Novi oblik soli pantoprazola
DE29821595U1 (de) Hufschuh
ATE263659T1 (de) Manipulator
NO20004528L (no) Cytostatiske midler
DE69806784T2 (de) Spieldose
FI980867A0 (fi) Laakerielin
DE69930738D1 (de) Oberflaechenaktive zusammensetzung
DE29803072U1 (de) Spielbrett
ID29414A (id) Pengobatan depresi
DE29706414U1 (de) Dreidimensionales Labyrinthspiel
DE29811543U1 (de) Kugelförmiges Geduldspiel
DE29515343U1 (de) Doppeltes Ziel für Pfeilspiele
DE29800931U1 (de) Schleuderballspiel
IT1302512B1 (it) Struttura di puzzle
ITPD980228A1 (it) Struttura di puzzle
DE29822902U1 (de) Gesellschaftsspiel
ES1041643Y (es) Juego tridimensional perfeccionado.
ITSV950007V0 (it) Postazione di gioco per giochi elettronici, virtuali, o simili.
BR9703679A (pt) Controlador para jogos de computador - teclado - joystick